Clin2
NCT07290699Possibly a fitNot yet recruiting

Intensive cholesterol treatment right after heart attack

STEMI - ST Elevation Myocardial InfarctionNSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests giving strong cholesterol-lowering medicine within 24 hours after a heart attack to see if it helps recovery. It is for people who have had a recent heart attack and are getting a stent placed.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
2,442 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You had a heart attack (STEMI or NSTEMI) within the past 24 hours.
  • You are able to understand and sign a consent form.
  • You cannot have severe heart failure or shock.
  • You must not be allergic to statins or cholesterol absorption inhibitors.
  • You cannot be pregnant or unable to have injections.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07208006Recruiting
Early cholesterol-lowering drug after heart attack

This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.

Shanghai, Shanghai Municipality
NCT04347434Recruiting· Phase 4
Long-term cholesterol medicines after heart attack

This trial studies how well long-term cholesterol-lowering treatment works in people who recently had a heart attack (STEMI or NSTEMI). It may help your care team understand which patients benefit most and how treatment should be continued safely.

Penza
NCT05587621Not yet recruiting
Intensive cholesterol lowering after heart attack

This study tests whether a stronger-than-usual cholesterol-lowering treatment right after a heart attack (STEMI or NSTEMI) can improve outcomes. It may help protect the heart by lowering harmful cholesterol quickly.

Jena, Thuringia
NCT04701242Recruiting
Early cholesterol medicine after heart attack

This trial looks at when and how to use cholesterol-lowering treatment soon after a heart attack. It may help people lower LDL (“bad” cholesterol) safely in the first days after an acute event.

Aswān
NCT06854523Not yet recruiting
Early PCSK9 inhibitor after heart attack for other artery blockages

This study tests whether starting a cholesterol-lowering drug called a PCSK9 inhibitor soon after a heart attack can help prevent future blockages. If you had a heart attack, received a stent, and have other arteries with minor blockages, this trial may be for you.

Beijing, Beijing Municipality
NCT07002476Recruiting· Phase 3
Early aggressive cholesterol-lowering after stroke with clot removal

This trial tests whether quickly starting an aggressive cholesterol-lowering treatment after a stroke improves recovery. It is for people who are about to have a procedure to remove a large blood clot from their brain.

Shanghai

Hear when a new STEMI - ST Elevation Myocardial Infarction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.